127 related articles for article (PubMed ID: 38350427)
1. Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
Noppakun K; Jitraknatee J; Suteeka Y; Ruengorn C; Nochaiwong S; Gunaparn S; Phrommintikul A; Wongcharoen W
Cardiorenal Med; 2024; 14(1):160-166. PubMed ID: 38350427
[TBL] [Abstract][Full Text] [Related]
2. Curcuminoids can prevent post-contrast acute kidney injury in chronic kidney disease patients: A randomized controlled trial.
Jaturapisanukul S; Kurathong S; Ngamvichchukorn T; Trakarnvanich T
Medicine (Baltimore); 2022 Sep; 101(39):e30753. PubMed ID: 36181056
[TBL] [Abstract][Full Text] [Related]
3. The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients.
Hami M; Bigdeli A; Khameneh Bagheri R; Rajabi O; Salehi M; Zahedi Avval F
Iran J Kidney Dis; 2019 Sep; 13(5):304-309. PubMed ID: 31705746
[TBL] [Abstract][Full Text] [Related]
4. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
[TBL] [Abstract][Full Text] [Related]
5. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
Padhy M; Kaushik S; Girish MP; Mohapatra S; Shah S; Koner BC
Clin Chim Acta; 2014 Aug; 435():48-52. PubMed ID: 24804935
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.
Panagiotou A; Trendelenburg M; Heijnen IAFM; Moser S; Bonati LH; Breidthardt T; Fahrni G; Kaiser C; Jeger R; Osthoff M
JACC Cardiovasc Interv; 2020 Apr; 13(7):833-842. PubMed ID: 32171721
[TBL] [Abstract][Full Text] [Related]
8. Preventive Effect of Trimetazidine on Contrast-Induced Acute Kidney Injury in CKD Patients Based on Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL): A randomized Clinical Trial.
Mirhosseni A; Farahani B; Gandomi-Mohammadabadi A; Keyvani H; Biglari-Abhari M; Davari A; Vazirizade-Mahabadi MH; Savaj S
Iran J Kidney Dis; 2019 May; 13(3):191-197. PubMed ID: 31209192
[TBL] [Abstract][Full Text] [Related]
9. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
[TBL] [Abstract][Full Text] [Related]
10. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
11. Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary Intervention.
Balbir Singh G; Ann SH; Park J; Chung HC; Lee JS; Kim ES; Choi JI; Lee J; Kim SJ; Shin ES
PLoS One; 2016; 11(10):e0164256. PubMed ID: 27723839
[TBL] [Abstract][Full Text] [Related]
12. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Rezaei Y; Khademvatani K; Rahimi B; Khoshfetrat M; Arjmand N; Seyyed-Mohammadzad MH
J Am Heart Assoc; 2016 Mar; 5(3):e002919. PubMed ID: 27068631
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
[TBL] [Abstract][Full Text] [Related]
14. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in the prediction of contrast media induced nephropathy - the BITCOIN study.
Seibert FS; Heringhaus A; Pagonas N; Rudolf H; Rohn B; Bauer F; Timmesfeld N; Trappe HJ; Babel N; Westhoff TH
PLoS One; 2020; 15(7):e0234921. PubMed ID: 32673348
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome.
Reyes LF; Severiche-Bueno DF; Bustamante CA; Murillo S; Soni NJ; Poveda M; Gomez E; Buitrago R; Rodriguez A
BMC Nephrol; 2020 Apr; 21(1):143. PubMed ID: 32321453
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
[TBL] [Abstract][Full Text] [Related]
19. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
[TBL] [Abstract][Full Text] [Related]
20. Prediction of contrast-induced acute kidney injury by early post-procedural analysis of urinary biomarkers and intra-renal Doppler flow indices in patients undergoing coronary angiography.
Wybraniec MT; Chudek J; Bożentowicz-Wikarek M; Mizia-Stec K
J Interv Cardiol; 2017 Oct; 30(5):465-472. PubMed ID: 28685874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
